Comparison of combination of fractional CO2 laser and daily topical steroid with intralesional steroid in alopecia areata

Comparison of Combination of Fractional CO2 Laser and Daily Topical Steroid with Intralesional Steroid in Alopecia Areata- Open Randomised Therapeutic Trial - NIL

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065363

Enrollment

Registered

2024-04-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L639- Alopecia areata, unspecified

Interventions

Intervention1: Fractional C02 laser and topical steroid Intralesional steroid: In group A lesion will be treated with ablative fractional CO2 laser followed by the daily local application of mometason

Eligibility

Inclusion criteria

Inclusion criteria: • Patients with patchy pattern of alopecia areata with two or more non-adjacent patches • Above the age of 18 years. • Not taken any form of treatment for at least 1 month.

Exclusion criteria

Exclusion criteria: 1• Patients with confluent scalp lesions, 2• Patients with other patterns of alopecia areata (alopecia universalis, alopecia totalis, ophiasis) 3• Patients on anticoagulant 4• Pregnancy and lactation • Patients with history of hypertrophic scar or keloid

Design outcomes

Primary

Measure	Time frame
assess hair regrowth after fractional co2 laser and topical application assess hair regrowth after intralesional steroid in alopecia areataTimepoint: baseline, 3 weeks, 6 weeks, 9 weeks, 12 weeks	—

Secondary

Measure	Time frame
Compare the proportion of hair regrowth in both groups using macdonald hull and norris grading and trichoscopic grading scores used. Timepoint: 12- 13 months	—

Countries

India

Contacts

Public ContactDr Vijay Gandhi

University College of medical sciences

drvj125@gmail.com9810296835

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026